HOME
FDA-approved Monotherapies
FDA-approved Combination Therapies
Intron A
Roferon

Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Digestive Disease Week (DDW) 2008 Online Abstract Submissions Due December 1

Digestive Disease Week is the world's largest educational forum for digestive disease academicians, clinicians, and researchers. This year’s meeting will be held May 17-22, 2008 in San Diego, CA.

With an expected attendance of 16,000 gastrointestinal professionals from around the world, DDW 2008 will be the premier meeting for clinical education, networking, and research, according to conference organizers. 

The 4 sponsoring societies of DDW invite researchers to submit abstracts for presentation at the DDW 2008 scientific sessions. The online abstract submission web site is now open, and will close Saturday, December 1, 2007, at 9:00 pm ET.
 
New Disclosure Requirements for DDW 2008
 
All authors in the abstract author string are required to complete their own financial disclosure statement on the DDW 2008 abstract submission site, either disclosing all financial relationships with commercial interests or indicating that none exist. Submitting authors will not be allowed to submit disclosures on behalf of a co-author.
 
Abstracts missing co-author financial disclosures will be in jeopardy of not being reviewed and involuntarily withdrawn from DDW 2008.
 
Researchers may now log in to update their contact information and complete their financial disclosures to ensure that any abstracts they are associated with will not be in jeopardy of rejection.

DDW 2008 abstract submission site: http://ddw2008.abstractcentral.com.

Please contact ddwprogram@gastro.org with any questions.  

11/27/07

Source
DDW Administration.
DDWprogram@gastro.org.

 

 

 

 

 

 

 

 Google Custom Search